Structure

Physi-Chem Properties

Molecular Weight:  274.08
Volume:  270.459
LogP:  2.922
LogD:  2.773
LogS:  -3.817
# Rotatable Bonds:  3
TPSA:  53.99
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.791
Synthetic Accessibility Score:  3.281
Fsp3:  0.267
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.669
MDCK Permeability:  2.3995553419808857e-05
Pgp-inhibitor:  0.981
Pgp-substrate:  0.005
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.014
30% Bioavailability (F30%):  0.653

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.374
Plasma Protein Binding (PPB):  96.65190124511719%
Volume Distribution (VD):  0.349
Pgp-substrate:  3.494689702987671%

ADMET: Metabolism

CYP1A2-inhibitor:  0.986
CYP1A2-substrate:  0.508
CYP2C19-inhibitor:  0.958
CYP2C19-substrate:  0.429
CYP2C9-inhibitor:  0.818
CYP2C9-substrate:  0.789
CYP2D6-inhibitor:  0.923
CYP2D6-substrate:  0.714
CYP3A4-inhibitor:  0.931
CYP3A4-substrate:  0.394

ADMET: Excretion

Clearance (CL):  10.898
Half-life (T1/2):  0.75

ADMET: Toxicity

hERG Blockers:  0.032
Human Hepatotoxicity (H-HT):  0.966
Drug-inuced Liver Injury (DILI):  0.79
AMES Toxicity:  0.878
Rat Oral Acute Toxicity:  0.063
Maximum Recommended Daily Dose:  0.898
Skin Sensitization:  0.947
Carcinogencity:  0.74
Eye Corrosion:  0.053
Eye Irritation:  0.497
Respiratory Toxicity:  0.913

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC193484

Natural Product ID:  NPC193484
Common Name*:   Methysticin
IUPAC Name:   (2R)-2-[(E)-2-(1,3-benzodioxol-5-yl)ethenyl]-4-methoxy-2,3-dihydropyran-6-one
Synonyms:   (+)-Methysticin; Methylsticin; Methysticin
Standard InCHIKey:  GTEXBOVBADJOQH-FWEMWIAWSA-N
Standard InCHI:  InChI=1S/C15H14O5/c1-17-12-7-11(20-15(16)8-12)4-2-10-3-5-13-14(6-10)19-9-18-13/h2-6,8,11H,7,9H2,1H3/b4-2+/t11-/m0/s1
SMILES:  COC1=CC(=O)O[C@@H](/C=C/c2ccc3c(c2)OCO3)C1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL579224
PubChem CID:   5281567
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0001761] Kavalactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26193 Piper methysticum Species Piperaceae Eukaryota n.a. n.a. n.a. PMID[11830162]
NPO26193 Piper methysticum Species Piperaceae Eukaryota n.a. n.a. n.a. PMID[12809361]
NPO26193 Piper methysticum Species Piperaceae Eukaryota root n.a. n.a. PMID[25597012]
NPO26193 Piper methysticum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26193 Piper methysticum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26193 Piper methysticum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO26193 Piper methysticum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT210 Individual Protein Thyroid stimulating hormone receptor Homo sapiens Potency = 39810.7 nM PMID[511510]
NPT539 Individual Protein Cellular tumor antigen p53 Homo sapiens Potency = 12589.3 nM PMID[511510]
NPT531 Individual Protein Nuclear receptor ROR-gamma Mus musculus Potency = 125.9 nM PMID[511510]
NPT109 Individual Protein Cytochrome P450 3A4 Homo sapiens Potency = 2511.9 nM PMID[511510]
NPT546 Individual Protein Retinoid X receptor alpha Homo sapiens Potency n.a. 14125.4 nM PMID[511510]
NPT540 Individual Protein Bile acid receptor FXR Homo sapiens Potency n.a. 39810.7 nM PMID[511510]
NPT152 Individual Protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 6682.4 nM PMID[511510]
NPT158 Individual Protein Nuclear receptor subfamily 1 group I member 2 Rattus norvegicus Potency n.a. 31622.8 nM PMID[511510]
NPT103 Individual Protein Nuclear receptor ROR-gamma Homo sapiens Potency n.a. 84.1 nM PMID[511510]
NPT66 Individual Protein Acetylcholinesterase Electrophorus electricus Inhibition = -4.34 % PMID[511512]
NPT152 Individual Protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 74978.0 nM PMID[511510]
NPT153 Individual Protein Androgen Receptor Homo sapiens Potency n.a. 6622.4 nM PubChem BioAssay data set
NPT2 Others Unspecified IC50 = 0.19 ug.mL-1 PMID[511508]
NPT27 Others Unspecified IC50 = 392.0 ug.mL-1 PMID[511508]
NPT93 Individual Protein Survival motor neuron protein Homo sapiens Potency = 5011.9 nM PMID[511510]
NPT94 Individual Protein Aldehyde dehydrogenase 1A1 Homo sapiens Potency = 25118.9 nM PMID[511510]
NPT67 Individual Protein Cholinesterase Equus caballus Inhibition = 0.15 % PMID[511512]
NPT2567 Organism Trichoderma viride Hypocrea rufa GI = 0.0 % PMID[511513]
NPT637 Organism Fusarium oxysporum Fusarium oxysporum GI = 36.2 % PMID[511513]
NPT637 Organism Fusarium oxysporum Fusarium oxysporum GI = 11.6 % PMID[511513]
NPT2600 Organism Fusarium solani Fusarium solani GI = 33.9 % PMID[511513]
NPT2600 Organism Fusarium solani Fusarium solani GI = 37.1 % PMID[511513]
NPT562 Organism Colletotrichum gloeosporioides Colletotrichum gloeosporioides GI = 0.0 % PMID[511513]
NPT117 Organism Echinochloa crus-galli Echinochloa crus-galli Inhibition = 83.9 % PMID[511513]
NPT117 Organism Echinochloa crus-galli Echinochloa crus-galli Inhibition = 75.4 % PMID[511513]
NPT117 Organism Echinochloa crus-galli Echinochloa crus-galli Inhibition = 56.0 % PMID[511513]
NPT117 Organism Echinochloa crus-galli Echinochloa crus-galli Inhibition = 55.0 % PMID[511513]
NPT117 Organism Echinochloa crus-galli Echinochloa crus-galli Inhibition = 60.0 % PMID[511513]
NPT117 Organism Echinochloa crus-galli Echinochloa crus-galli Inhibition = 50.0 % PMID[511513]
NPT364 Organism Lactuca sativa Lactuca sativa Inhibition = 53.1 % PMID[511513]
NPT364 Organism Lactuca sativa Lactuca sativa Inhibition = 61.2 % PMID[511513]
NPT364 Organism Lactuca sativa Lactuca sativa Inhibition = 73.3 % PMID[511513]
NPT364 Organism Lactuca sativa Lactuca sativa Inhibition = 71.1 % PMID[511513]
NPT364 Organism Lactuca sativa Lactuca sativa Inhibition = 55.6 % PMID[511513]
NPT364 Organism Lactuca sativa Lactuca sativa Inhibition = 48.1 % PMID[511513]
NPT610 Others Molecular identity unknown Potency n.a. 891.3 nM PMID[511510]
NPT2 Others Unspecified Potency n.a. 9354.4 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 46882.9 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 65.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 10408.1 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 58.5 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 414.4 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 14825.7 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 10495.8 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 52603.5 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 41784.4 nM PubChem BioAssay data set
NPT2 Others Unspecified Potency n.a. 8267.4 nM PubChem BioAssay data set

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC193484 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9661 High Similarity NPC85830
0.9391 High Similarity NPC212643
0.9391 High Similarity NPC199209
0.9322 High Similarity NPC114845
0.9231 High Similarity NPC69670
0.9068 High Similarity NPC57501
0.8974 High Similarity NPC111225
0.886 High Similarity NPC127326
0.8824 High Similarity NPC277460
0.877 High Similarity NPC256167
0.8678 High Similarity NPC2058
0.8644 High Similarity NPC294941
0.8626 High Similarity NPC20796
0.8621 High Similarity NPC31279
0.8595 High Similarity NPC37858
0.8583 High Similarity NPC476748
0.8561 High Similarity NPC226005
0.8547 High Similarity NPC245552
0.8525 High Similarity NPC202474
0.8512 High Similarity NPC124916
0.8473 Intermediate Similarity NPC240915
0.8473 Intermediate Similarity NPC73071
0.8468 Intermediate Similarity NPC288238
0.8462 Intermediate Similarity NPC179309
0.8455 Intermediate Similarity NPC204466
0.843 Intermediate Similarity NPC33271
0.8425 Intermediate Similarity NPC64948
0.8421 Intermediate Similarity NPC109637
0.8409 Intermediate Similarity NPC157554
0.8409 Intermediate Similarity NPC37468
0.8403 Intermediate Similarity NPC303522
0.84 Intermediate Similarity NPC21238
0.8397 Intermediate Similarity NPC7163
0.8387 Intermediate Similarity NPC70752
0.8374 Intermediate Similarity NPC222175
0.8374 Intermediate Similarity NPC344161
0.8361 Intermediate Similarity NPC159916
0.8361 Intermediate Similarity NPC164706
0.8361 Intermediate Similarity NPC137537
0.8361 Intermediate Similarity NPC272471
0.8361 Intermediate Similarity NPC107588
0.8361 Intermediate Similarity NPC70744
0.8346 Intermediate Similarity NPC166184
0.8333 Intermediate Similarity NPC246704
0.8321 Intermediate Similarity NPC205915
0.8306 Intermediate Similarity NPC471877
0.8306 Intermediate Similarity NPC267064
0.8293 Intermediate Similarity NPC119949
0.8284 Intermediate Similarity NPC100389
0.8271 Intermediate Similarity NPC143895
0.8271 Intermediate Similarity NPC102260
0.8271 Intermediate Similarity NPC186418
0.8271 Intermediate Similarity NPC230968
0.8268 Intermediate Similarity NPC289459
0.8268 Intermediate Similarity NPC27352
0.8254 Intermediate Similarity NPC279379
0.8248 Intermediate Similarity NPC110063
0.8248 Intermediate Similarity NPC297342
0.8246 Intermediate Similarity NPC310905
0.8246 Intermediate Similarity NPC12714
0.824 Intermediate Similarity NPC80241
0.824 Intermediate Similarity NPC301641
0.824 Intermediate Similarity NPC310373
0.8231 Intermediate Similarity NPC19242
0.8222 Intermediate Similarity NPC278076
0.8217 Intermediate Similarity NPC226862
0.8217 Intermediate Similarity NPC165128
0.8217 Intermediate Similarity NPC57119
0.8217 Intermediate Similarity NPC158471
0.8205 Intermediate Similarity NPC258171
0.8203 Intermediate Similarity NPC127604
0.8203 Intermediate Similarity NPC120225
0.8203 Intermediate Similarity NPC213552
0.8197 Intermediate Similarity NPC268317
0.8195 Intermediate Similarity NPC55040
0.8195 Intermediate Similarity NPC477301
0.8189 Intermediate Similarity NPC146886
0.8189 Intermediate Similarity NPC20443
0.8189 Intermediate Similarity NPC60517
0.8188 Intermediate Similarity NPC83743
0.8188 Intermediate Similarity NPC262182
0.8188 Intermediate Similarity NPC287615
0.8188 Intermediate Similarity NPC216819
0.8188 Intermediate Similarity NPC476450
0.8174 Intermediate Similarity NPC179686
0.8168 Intermediate Similarity NPC227160
0.8168 Intermediate Similarity NPC82111
0.8148 Intermediate Similarity NPC178290
0.814 Intermediate Similarity NPC158737
0.814 Intermediate Similarity NPC223807
0.814 Intermediate Similarity NPC286683
0.814 Intermediate Similarity NPC194841
0.8134 Intermediate Similarity NPC11453
0.813 Intermediate Similarity NPC65791
0.813 Intermediate Similarity NPC185738
0.813 Intermediate Similarity NPC280001
0.8125 Intermediate Similarity NPC120066
0.812 Intermediate Similarity NPC309953
0.812 Intermediate Similarity NPC110958
0.812 Intermediate Similarity NPC19890
0.8106 Intermediate Similarity NPC137669
0.8106 Intermediate Similarity NPC252833
0.8106 Intermediate Similarity NPC7744
0.8103 Intermediate Similarity NPC292792
0.8102 Intermediate Similarity NPC473873
0.8102 Intermediate Similarity NPC157816
0.8102 Intermediate Similarity NPC104956
0.8102 Intermediate Similarity NPC140502
0.8102 Intermediate Similarity NPC473792
0.8092 Intermediate Similarity NPC233224
0.8092 Intermediate Similarity NPC477705
0.8092 Intermediate Similarity NPC271208
0.8092 Intermediate Similarity NPC233961
0.8092 Intermediate Similarity NPC244799
0.8092 Intermediate Similarity NPC339621
0.8092 Intermediate Similarity NPC477694
0.8092 Intermediate Similarity NPC280399
0.8092 Intermediate Similarity NPC240722
0.8088 Intermediate Similarity NPC202700
0.8077 Intermediate Similarity NPC110313
0.8077 Intermediate Similarity NPC302378
0.8077 Intermediate Similarity NPC109275
0.8077 Intermediate Similarity NPC210674
0.8074 Intermediate Similarity NPC14022
0.8065 Intermediate Similarity NPC205502
0.8062 Intermediate Similarity NPC473960
0.806 Intermediate Similarity NPC469808
0.8051 Intermediate Similarity NPC227894
0.8047 Intermediate Similarity NPC283170
0.8047 Intermediate Similarity NPC92869
0.8047 Intermediate Similarity NPC191768
0.8045 Intermediate Similarity NPC241341
0.8045 Intermediate Similarity NPC284855
0.8045 Intermediate Similarity NPC136750
0.8045 Intermediate Similarity NPC266848
0.8045 Intermediate Similarity NPC6836
0.8045 Intermediate Similarity NPC254398
0.8045 Intermediate Similarity NPC233018
0.8045 Intermediate Similarity NPC25821
0.8045 Intermediate Similarity NPC36437
0.8045 Intermediate Similarity NPC282477
0.8043 Intermediate Similarity NPC478239
0.8034 Intermediate Similarity NPC128730
0.8031 Intermediate Similarity NPC211231
0.803 Intermediate Similarity NPC219677
0.803 Intermediate Similarity NPC477706
0.803 Intermediate Similarity NPC192255
0.8029 Intermediate Similarity NPC51681
0.8017 Intermediate Similarity NPC131530
0.8015 Intermediate Similarity NPC166040
0.8015 Intermediate Similarity NPC295970
0.8015 Intermediate Similarity NPC27239
0.8015 Intermediate Similarity NPC123127
0.8015 Intermediate Similarity NPC48315
0.8015 Intermediate Similarity NPC248355
0.8015 Intermediate Similarity NPC26653
0.8015 Intermediate Similarity NPC270849
0.8015 Intermediate Similarity NPC307110
0.8015 Intermediate Similarity NPC83062
0.8014 Intermediate Similarity NPC192763
0.8014 Intermediate Similarity NPC308178
0.8014 Intermediate Similarity NPC300262
0.8014 Intermediate Similarity NPC261122
0.8014 Intermediate Similarity NPC28651
0.8014 Intermediate Similarity NPC199311
0.8014 Intermediate Similarity NPC210611
0.8014 Intermediate Similarity NPC80732
0.8014 Intermediate Similarity NPC3460
0.8014 Intermediate Similarity NPC215095
0.8014 Intermediate Similarity NPC201148
0.8 Intermediate Similarity NPC241634
0.7986 Intermediate Similarity NPC15743
0.7986 Intermediate Similarity NPC50696
0.7985 Intermediate Similarity NPC135127
0.7985 Intermediate Similarity NPC67247
0.7985 Intermediate Similarity NPC471883
0.7985 Intermediate Similarity NPC470881
0.7984 Intermediate Similarity NPC300326
0.7984 Intermediate Similarity NPC39793
0.7984 Intermediate Similarity NPC58279
0.7984 Intermediate Similarity NPC17348
0.7971 Intermediate Similarity NPC176586
0.7971 Intermediate Similarity NPC287124
0.7971 Intermediate Similarity NPC210354
0.797 Intermediate Similarity NPC319969
0.797 Intermediate Similarity NPC171928
0.797 Intermediate Similarity NPC65183
0.797 Intermediate Similarity NPC100223
0.797 Intermediate Similarity NPC158526
0.797 Intermediate Similarity NPC72046
0.797 Intermediate Similarity NPC261812
0.797 Intermediate Similarity NPC5423
0.797 Intermediate Similarity NPC16830
0.797 Intermediate Similarity NPC473924
0.797 Intermediate Similarity NPC33611
0.797 Intermediate Similarity NPC129687
0.7969 Intermediate Similarity NPC108545
0.7969 Intermediate Similarity NPC470887
0.7969 Intermediate Similarity NPC249788
0.7967 Intermediate Similarity NPC233669

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC193484 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8443 Intermediate Similarity NPD1357 Approved
0.8362 Intermediate Similarity NPD1358 Approved
0.824 Intermediate Similarity NPD3705 Approved
0.813 Intermediate Similarity NPD5536 Phase 2
0.7966 Intermediate Similarity NPD3134 Approved
0.7805 Intermediate Similarity NPD5283 Phase 1
0.7801 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7721 Intermediate Similarity NPD2492 Phase 1
0.7708 Intermediate Similarity NPD1653 Approved
0.7692 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7642 Intermediate Similarity NPD228 Approved
0.7639 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD5691 Approved
0.7518 Intermediate Similarity NPD1933 Approved
0.75 Intermediate Similarity NPD7266 Discontinued
0.7438 Intermediate Similarity NPD9697 Approved
0.7372 Intermediate Similarity NPD554 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD969 Suspended
0.7348 Intermediate Similarity NPD2981 Phase 2
0.7343 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD4110 Phase 3
0.7333 Intermediate Similarity NPD9494 Approved
0.7328 Intermediate Similarity NPD3496 Discontinued
0.7302 Intermediate Similarity NPD5535 Approved
0.7293 Intermediate Similarity NPD2983 Phase 2
0.7293 Intermediate Similarity NPD2982 Phase 2
0.7267 Intermediate Similarity NPD37 Approved
0.7266 Intermediate Similarity NPD447 Suspended
0.7252 Intermediate Similarity NPD4626 Approved
0.7246 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD1241 Discontinued
0.7237 Intermediate Similarity NPD4967 Phase 2
0.7237 Intermediate Similarity NPD4965 Approved
0.7237 Intermediate Similarity NPD4966 Approved
0.7226 Intermediate Similarity NPD3027 Phase 3
0.7219 Intermediate Similarity NPD5563 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD556 Approved
0.719 Intermediate Similarity NPD291 Approved
0.7177 Intermediate Similarity NPD290 Approved
0.7176 Intermediate Similarity NPD5585 Approved
0.7143 Intermediate Similarity NPD6234 Discontinued
0.7143 Intermediate Similarity NPD422 Phase 1
0.7143 Intermediate Similarity NPD1091 Approved
0.7133 Intermediate Similarity NPD7028 Phase 2
0.7123 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD2684 Approved
0.7105 Intermediate Similarity NPD1282 Approved
0.7092 Intermediate Similarity NPD2653 Approved
0.708 Intermediate Similarity NPD3018 Phase 2
0.7071 Intermediate Similarity NPD4060 Phase 1
0.7063 Intermediate Similarity NPD2438 Suspended
0.7051 Intermediate Similarity NPD7199 Phase 2
0.7032 Intermediate Similarity NPD919 Approved
0.7031 Intermediate Similarity NPD7843 Approved
0.7029 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD6355 Discontinued
0.7015 Intermediate Similarity NPD1281 Approved
0.7015 Intermediate Similarity NPD776 Approved
0.7014 Intermediate Similarity NPD1375 Discontinued
0.7 Intermediate Similarity NPD7157 Approved
0.7 Intermediate Similarity NPD6233 Phase 2
0.6992 Remote Similarity NPD1778 Approved
0.6978 Remote Similarity NPD7095 Approved
0.6975 Remote Similarity NPD7685 Pre-registration
0.6972 Remote Similarity NPD6653 Approved
0.697 Remote Similarity NPD1182 Approved
0.6962 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6959 Remote Similarity NPD5297 Approved
0.695 Remote Similarity NPD4140 Approved
0.695 Remote Similarity NPD1612 Clinical (unspecified phase)
0.695 Remote Similarity NPD1613 Approved
0.6948 Remote Similarity NPD3817 Phase 2
0.6937 Remote Similarity NPD3818 Discontinued
0.6929 Remote Similarity NPD6798 Discontinued
0.6923 Remote Similarity NPD7097 Phase 1
0.6918 Remote Similarity NPD4237 Approved
0.6918 Remote Similarity NPD6674 Discontinued
0.6918 Remote Similarity NPD4236 Phase 3
0.6918 Remote Similarity NPD1652 Phase 2
0.6912 Remote Similarity NPD4359 Approved
0.6906 Remote Similarity NPD1008 Clinical (unspecified phase)
0.6901 Remote Similarity NPD230 Phase 1
0.6901 Remote Similarity NPD4340 Discontinued
0.6901 Remote Similarity NPD3657 Discovery
0.6901 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6889 Remote Similarity NPD1611 Approved
0.6879 Remote Similarity NPD4062 Phase 3
0.6867 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6866 Remote Similarity NPD17 Approved
0.6863 Remote Similarity NPD6386 Approved
0.6863 Remote Similarity NPD6385 Approved
0.6861 Remote Similarity NPD2922 Phase 1
0.6861 Remote Similarity NPD1283 Approved
0.6846 Remote Similarity NPD4357 Discontinued
0.6842 Remote Similarity NPD1894 Discontinued
0.6839 Remote Similarity NPD5353 Approved
0.6832 Remote Similarity NPD7228 Approved
0.6831 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6831 Remote Similarity NPD2979 Phase 3
0.6831 Remote Similarity NPD3620 Phase 2
0.6824 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6818 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6815 Remote Similarity NPD3847 Discontinued
0.6812 Remote Similarity NPD3266 Approved
0.6812 Remote Similarity NPD3267 Approved
0.6809 Remote Similarity NPD5109 Approved
0.6809 Remote Similarity NPD5110 Phase 2
0.6809 Remote Similarity NPD5111 Phase 2
0.68 Remote Similarity NPD4739 Approved
0.68 Remote Similarity NPD3146 Approved
0.68 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6791 Remote Similarity NPD1651 Approved
0.679 Remote Similarity NPD7054 Approved
0.6788 Remote Similarity NPD5327 Phase 3
0.6786 Remote Similarity NPD6832 Phase 2
0.6786 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6781 Remote Similarity NPD5762 Approved
0.6781 Remote Similarity NPD5763 Approved
0.6776 Remote Similarity NPD3686 Approved
0.6776 Remote Similarity NPD4210 Discontinued
0.6776 Remote Similarity NPD3687 Approved
0.6774 Remote Similarity NPD2978 Approved
0.6774 Remote Similarity NPD1006 Clinical (unspecified phase)
0.6774 Remote Similarity NPD2977 Approved
0.6763 Remote Similarity NPD1019 Discontinued
0.6759 Remote Similarity NPD4108 Discontinued
0.6757 Remote Similarity NPD6331 Phase 2
0.6757 Remote Similarity NPD4628 Phase 3
0.6757 Remote Similarity NPD6658 Clinical (unspecified phase)
0.6755 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6748 Remote Similarity NPD7472 Approved
0.6742 Remote Similarity NPD709 Approved
0.6739 Remote Similarity NPD3225 Approved
0.6735 Remote Similarity NPD2424 Discontinued
0.6735 Remote Similarity NPD1372 Clinical (unspecified phase)
0.6735 Remote Similarity NPD970 Clinical (unspecified phase)
0.6732 Remote Similarity NPD3866 Clinical (unspecified phase)
0.673 Remote Similarity NPD8127 Discontinued
0.6727 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6716 Remote Similarity NPD9545 Approved
0.6715 Remote Similarity NPD9717 Approved
0.6715 Remote Similarity NPD1608 Approved
0.6715 Remote Similarity NPD1840 Phase 2
0.6714 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6712 Remote Similarity NPD2935 Discontinued
0.6712 Remote Similarity NPD2161 Phase 2
0.6712 Remote Similarity NPD6032 Approved
0.6711 Remote Similarity NPD6190 Approved
0.671 Remote Similarity NPD1934 Approved
0.6707 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6694 Remote Similarity NPD9296 Approved
0.6693 Remote Similarity NPD968 Approved
0.6692 Remote Similarity NPD1139 Approved
0.6692 Remote Similarity NPD1137 Approved
0.6691 Remote Similarity NPD987 Approved
0.6691 Remote Similarity NPD2797 Approved
0.669 Remote Similarity NPD5718 Phase 2
0.669 Remote Similarity NPD6859 Clinical (unspecified phase)
0.669 Remote Similarity NPD1296 Phase 2
0.669 Remote Similarity NPD1048 Approved
0.6689 Remote Similarity NPD4162 Approved
0.6688 Remote Similarity NPD3882 Suspended
0.6667 Remote Similarity NPD7240 Approved
0.6667 Remote Similarity NPD5058 Phase 3
0.6667 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5494 Approved
0.6667 Remote Similarity NPD3685 Discontinued
0.6667 Remote Similarity NPD5451 Approved
0.6667 Remote Similarity NPD5124 Phase 1
0.6646 Remote Similarity NPD7074 Phase 3
0.6645 Remote Similarity NPD6873 Phase 2
0.6645 Remote Similarity NPD3647 Clinical (unspecified phase)
0.6644 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6644 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6644 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6643 Remote Similarity NPD4870 Approved
0.6643 Remote Similarity NPD8032 Phase 2
0.6643 Remote Similarity NPD5647 Approved
0.6642 Remote Similarity NPD1535 Discovery
0.6641 Remote Similarity NPD821 Approved
0.6641 Remote Similarity NPD1138 Approved
0.6627 Remote Similarity NPD7808 Phase 3
0.6625 Remote Similarity NPD1247 Approved
0.6623 Remote Similarity NPD7458 Discontinued
0.662 Remote Similarity NPD2669 Clinical (unspecified phase)
0.6619 Remote Similarity NPD1876 Approved
0.6606 Remote Similarity NPD6797 Phase 2
0.66 Remote Similarity NPD5307 Clinical (unspecified phase)
0.66 Remote Similarity NPD3887 Approved
0.6599 Remote Similarity NPD3539 Phase 1
0.6599 Remote Similarity NPD2531 Phase 2
0.6597 Remote Similarity NPD4307 Phase 2
0.6597 Remote Similarity NPD1558 Phase 1
0.6594 Remote Similarity NPD1481 Phase 2
0.6593 Remote Similarity NPD1548 Phase 1
0.6583 Remote Similarity NPD9365 Approved
0.6582 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6577 Remote Similarity NPD3060 Approved
0.6575 Remote Similarity NPD6896 Approved
0.6575 Remote Similarity NPD6895 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data